BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10382684)

  • 1. Solitary nodular disease and multinodular goiter: a retrospective study on suppressive versus replacement levothyroxine therapy.
    Paggi A; Persegani-Trimarchi C; Russo P; Mastropasqua M; Mosetti MA; Losi T; Leri O
    Endocr Res; 1999 May; 25(2):229-38. PubMed ID: 10382684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
    Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
    Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
    Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
    Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter.
    Güllü S; Gürses MA; Başkal N; Uysal AR; Kamel AN; Erdoğan G
    Endocr J; 1999 Feb; 46(1):221-6. PubMed ID: 10426591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
    Celani MF
    Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
    Celani MF; Mariani M; Mariani G
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
    Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
    Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
    Papini E; Petrucci L; Guglielmi R; Panunzi C; Rinaldi R; Bacci V; Crescenzi A; Nardi F; Fabbrini R; Pacella CM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules.
    Morita T; Tamai H; Ohshima A; Komaki G; Matsubayashi S; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Aug; 69(2):227-30. PubMed ID: 2753971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study.
    Carella C; Mazziotti G; Rotondi M; Del Buono A; Zito G; Sorvillo F; Manganella G; Santini L; Amato G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):507-13. PubMed ID: 12354133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
    Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size.
    Baldini M; Gallazzi M; Orsatti A; Fossati S; Leonardi P; Cantalamessa L
    J Intern Med; 2002 May; 251(5):407-14. PubMed ID: 11982740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy with L-thyroxine in thyroid struma. Study with ultrasonic evaluation].
    Peta M; Cartasegna S; Fabiani MP; Macchi R; Vecchi G; Costantino D
    Recenti Prog Med; 1989 Jun; 80(6):320-5. PubMed ID: 2672195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.
    Bennedbaek FN; Nielsen LK; Hegedüs L
    J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
    Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
    J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: a retrospective study.
    Alba M; Fintini D; Lovicu RM; Paragliola RM; Papi G; Rota CA; Pontecorvi A; Corsello SM
    J Endocrinol Invest; 2009 Apr; 32(4):330-4. PubMed ID: 19636201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.
    Samuels MH; Kolobova I; Smeraglio A; Peters D; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2014 Mar; 99(3):843-51. PubMed ID: 24423358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.